Total Pageviews

Sunday 31 July 2011

Why James Murdoch Is Now a Headache for Glaxo !

GlaxoSmithKline (GSK) CEO Andrew Witty is no doubt gnashing his teeth over James Murdoch’s testimony to the U.K. parliament yesterday on the phone hacking scandal at News Corp. (NWS). Murdoch has sat on GSK’s board of directors since 2009. Murdoch is on the two of GSK’s board committees, corporate responsibility and remuneration. He now looks like an unfortunate candidate for both those jobs.
 
 
 

No comments: